First hepatitis E outbreak in Southeastern Senegal.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 10 2022
Historique:
received: 05 08 2022
accepted: 14 10 2022
entrez: 25 10 2022
pubmed: 26 10 2022
medline: 28 10 2022
Statut: epublish

Résumé

The Rapid proliferation of traditional gold mining sites in the Kedougou region has led to massive migration of people from neighbouring West African countries and the establishment of several small villages where poor hygiene and sanitation conditions exist. In this context, a Hepatitis E virus outbreak was reported in Kedougou in 2014 with several cases among the traditional mining workers. Herein, we described epidemiological and laboratory data collected during the outbreak's investigation from February 2012 to November 2014. Any suspected, contact or probable case was investigated, clinical and epidemiological data were collected. In our study, sera were collected and tested for viral RNA and anti-Hepatitis E virus (HEV) IgM. Archived serum samples from Kedougou were retrospectively screened by real-time polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). A total of 65 water samples collected from ponds and wells surrounding gold panners' sites and habitats and 75 tissues samples from rats captured in the environment of traditional gold mining sites were also tested. A total of 1617 sera were collected from 698 suspected cases, 862 contacts and 57 persons with missing information. The median age was 20 (1-88 years-old) and the sex ratio was 1.72. An overall rate of 64.62% (1045/1617) of these patients tested positive for HEV with a high case fatality rate in pregnant women. All water samples and animal tissues tested negative for HEV. Our data help not only determining of the beginning of the HEV outbreak to March 2012, but also identifying risk factors associated to its emergence. However, there is a need to implement routine diagnosis, surveillance and training of health personnel in order to reduce mortality especially among pregnant women. In addition, further studies are needed to identify the virus reservoir and environmental risk factors for HEV in the Kedougou region.

Identifiants

pubmed: 36284151
doi: 10.1038/s41598-022-22491-8
pii: 10.1038/s41598-022-22491-8
pmc: PMC9596447
doi:

Substances chimiques

RNA, Viral 0
Hepatitis Antibodies 0
Immunoglobulin M 0
Gold 7440-57-5
Water 059QF0KO0R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

17878

Informations de copyright

© 2022. The Author(s).

Références

World J Gastroenterol. 2016 Aug 21;22(31):7030-45
pubmed: 27610014
Science. 1990 Mar 16;247(4948):1335-9
pubmed: 2107574
Rev Med Virol. 2007 May-Jun;17(3):151-80
pubmed: 17051624
J Med Microbiol. 2015 Jul;64(7):752-758
pubmed: 25976003
Virology (Auckl). 2014 May 27;5:15-26
pubmed: 25512696
Virology. 1991 Nov;185(1):120-31
pubmed: 1926770
Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9860-5
pubmed: 9275216
Indian J Gastroenterol. 1992 Jul;11(3):113-6
pubmed: 1506045
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
Mediterr J Hematol Infect Dis. 2010 Feb 10;2(1):e2010001
pubmed: 21415943
Clin Infect Dis. 2010 Aug 1;51(3):328-34
pubmed: 20572761
J Virol. 2010 Jan;84(2):765-72
pubmed: 19889759
Trop Med Int Health. 2016 Jan;21(1):108-113
pubmed: 26523476
Microbiol Resour Announc. 2019 Jan 3;8(1):
pubmed: 30637389
Cold Spring Harb Perspect Med. 2019 Jan 2;9(1):
pubmed: 29530948
Ther Adv Infect Dis. 2019 Apr 03;6:2049936119837162
pubmed: 30984394
Indian J Med Microbiol. 2015 Feb;33 Suppl:102-5
pubmed: 25657123
J Hepatol. 2016 Apr;64(4):933-45
pubmed: 26658682
Med Sci (Paris). 2018 Dec;34(12):1071-1078
pubmed: 30623765
Future Microbiol. 2016 Jun;11:789-808
pubmed: 27203841
World J Gastroenterol. 2022 Jan 7;28(1):76-95
pubmed: 35125820
Virol J. 2018 Oct 23;15(1):163
pubmed: 30352598
N Engl J Med. 2008 Feb 21;358(8):811-7
pubmed: 18287603
Hepatology. 2012 Apr;55(4):988-97
pubmed: 22121109
World J Gastroenterol. 2020 Oct 7;26(37):5543-5560
pubmed: 33071523
J Med Virol. 2006 Aug;78(8):1076-82
pubmed: 16789018
Nat Rev Gastroenterol Hepatol. 2018 Feb;15(2):96-110
pubmed: 29162935
J Viral Hepat. 2015 Oct;22(10):850-7
pubmed: 25760656

Auteurs

Bacary Djilocalisse Sadio (BD)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.
Service de Santé Publique et Appui à la Recherche (CHU Fann), Institut de Santé et Développement, Dakar, Senegal.
Université Cheikh Anta Diop de Dakar, Dakar, Senegal.

Martin Faye (M)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal. martin.faye@pasteur.sn.

Marco Kaiser (M)

GenExpress GmbH, 12103, Berlin, Germany.

Maryam Diarra (M)

Epidemiology, Clinical Research and Data Science Unit, Institut Pasteur de Dakar, 220, Dakar, Senegal.

Fanny Balique (F)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.
OZ Biosciences SAS, 13288, Marseille Cedex 09, France.

Cheikh Tidiane Diagne (CT)

MIVEGEC (Infectious Diseases and Vector: Ecology, Genetics, Evolution and Control), Univ. Montpelier, IRD, CNRS, 34394, Montpellier, France.

Oumar Faye (O)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.

Moussa Moïse Diagne (MM)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.

Gamou Fall (G)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.

Oumar Ndiaye (O)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.

Cheikh Loucoubar (C)

Epidemiology, Clinical Research and Data Science Unit, Institut Pasteur de Dakar, 220, Dakar, Senegal.

Abdourahmane Sow (A)

West African Health Organisation, 175, Avenue Ouezzin Coulibaly, 01BP: 153, Bobo Dioulasso 01, Burkina Faso.

Ousmane Faye (O)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.

Adama Faye (A)

Service de Santé Publique et Appui à la Recherche (CHU Fann), Institut de Santé et Développement, Dakar, Senegal.
Université Cheikh Anta Diop de Dakar, Dakar, Senegal.

Cheikh Saad Bouh Boye (CSB)

Université Cheikh Anta Diop de Dakar, Dakar, Senegal.
Unité de Recherche et Biotechnologie Microbienne, Faculté de Médecine, de Pharmacie et d'Odontostomatologie (FMPOS), Dakar, Senegal.

Amadou Alpha Sall (AA)

Virology Department, Institut Pasteur de Dakar, 36, Avenue Pasteur, 220, Dakar, Senegal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH